The challenge of neuropsychiatric issues in pediatric epilepsy

Journal of Child Neurology

Volumn 19, Issue SUPPL. 1, 2004, Pages

  Pellock, John M ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ANTICONVULSIVE AGENT; BARBITURIC ACID DERIVATIVE; CARBAMAZEPINE; CHLORPROMAZINE; CLOMIPRAMINE; CLOZAPINE; ETIRACETAM; GABAPENTIN; LAMOTRIGINE; MAPROTILINE; METHYLPHENIDATE; NEUROLEPTIC AGENT; PHENOBARBITAL; PHENYTOIN; PSYCHOTROPIC AGENT; SEROTONIN UPTAKE INHIBITOR; VALPROIC ACID;

ARTICLE; ATTENTION DEFICIT DISORDER; BEHAVIOR DISORDER; CHILD; CHILD HEALTH CARE; CLINICAL FEATURE; COGNITIVE DEFECT; COMORBIDITY; DEPRESSION; DISEASE EXACERBATION; DRUG POTENTIATION; EPILEPSY; HUMAN; HYPERACTIVITY; IRRITABILITY; MENTAL DISEASE; NEUROPSYCHIATRY; NEUROPSYCHOLOGICAL TEST; PEDIATRICS; PRIORITY JOURNAL; PSYCHOSIS; SEIZURE; SOMNOLENCE;

EID: 8344266942     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: 10.1177/088307380401900101     Document Type: Article

References (58)

1. Shinnar S, Pellock JM: Update on the epidemiology and prognosis of pediatric epilepsy. J Child Neurol 2002; 17(Suppl 1):S4-S17.
2. Hauser WA, Annegers JF, Kurland LT: Incidence of epilepsy and unprovoked seizures in Rochester, Minnesota: 1935-1984. Epilepsia 1993;34:453-468.
3. Hauser WA: Incidence and prevalence, in Engel J Jr, Pedley TA (eds): Epilepsy: A Comprehensive Textbook. Philadelphia, Lippincott-Raven Publishers, 1997, 47-57.
4. Goulden KJ, Shinnar S, Koller H, et al: Epilepsy in children with mental retardation: A cohort study. Epilepsia 1991; 32:690-697.
5. Kudrjavcev T, Schoenberg BS, Kurland LT, Groover RV. Cerebral palsy: Survival rates, associated handicaps, and distribution by clinical subtype (Rochester, MN, 1950-1976). Neurology1985;35: 900-903.
6. Wong V. Epilepsy in children with autistic spectrum disorder. J Child Neurol 1993;8:316-322.
7. Olsson I, Steffenburg S, Gillberg C: Epilepsy in autism and autisticlike conditions. A population-based study. Arch Neurol 1988;45:666-668.
8. Volkmar FR, Nelson DS: Seizure disorders in autism. J Am Acad Child Adolesc Psychiatry 1990;29:127-129.
9. Dodson WE: Epilepsy, cerebral palsy, and IQ, in Pellock JM, Dodson WE, Bourgeois BFD (eds): Pediatric Epilepsy: Diagnosis and Therapy, 2nd ed. New York, Demos Publishing, Inc, 2001,613-627.
10. Steffenburg U, Hagberg G, Viggedal G, Kyllerman M: Active epilepsy in mentally retarded children. I. Prevalence and additional neuroimpairments. Acta Paediatr 1995;84:1147-1152.
11. Rutter M, Graham F, Yule W. The prevalence of psychiatric disorder in neuro-epileptic children, in: A neuropsychiatric study in childhood. Philadelphia, JB Lippincott Co, 1970, 175-185. Clinics in Developmental Medicine, vol 35/36.
12. Ott D, Siddarth P, Gurbani S, et al: Behavioral disorders in pediatric epilepsy: Unmet psychiatric need. Epilepsia 2003;44:591-597.
13. Caplan R, Arbelle S, Magharious W, et al: Psychopathology in pediatric complex partial and primary generalized epilepsy. Dev Med Child Neurol 1998;40:805-811.
14. Ott D, Caplan R, Guthrie D, et al: Measures of psychopathology in children with complex partial seizures and primary generalized epilepsy with absence. J Am Acad Child Adolesc Psychiatry 2001;40:907-914.
15. Ettinger AB, Weisbrot DM, Nolan EE, et al: Symptoms of depression and anxiety in pediatric epilepsy patients. Epilepsia 1998;39:595-599.
16. Oguz A, Kurul S, Dirik E: Relationship of epilepsy-related factors to anxiety and depression scores in epileptic children. J Child Neurol 2002;17:37-40.
17. Williams J, Griebel ML, Dykman RA: Neuropsychological patterns in pediatric epilepsy. Seizure 1998;7:223-228.
18. Hempel AM, Frost MD, Ritter FJ, Farnham S: Factors influencing the incidence of ADHD in pediatric epilepsy patients, abstract. Epilepsia 1995;36(Suppl 4):122.
19. Semrud-Clikeman M, Wical B: Components of attention in children with complex partial seizures with and without ADHD. Epilepsia 1999;40:211-215.
20. Hemmer SA, Pasternak JF, Zecker SG, Trommer BL: Stimulant therapy and seizure risk in children with ADHD. Pediatr Neurol 2001;24:99-102.
21. Gross-Tsur V, Manor O, van der Meere J, et al: Epilepsy and attention deficit hyperactivity disorder: Is methylphenidate safe and effective? J Pediatr 1997; 130:670-674.
22. Caplan R, Arbelle S, Guthrie D, et al: Formal thought disorder and psychopathology in pediatric primary generalized and complex partial epilepsy. J Am Acad Child Adolesc Psychiatry 1997;36: 1286-1294.
23. Weissman MM, Wolk S, Goldstein RB, et al: Depressed adolescents grown up. JAMA 1999;281:1707-1713.
24. Angold A, Costello EJ, Messer SC, et al: Development of a short questionnaire for use in epidemiological studies of depression in children and adolescents. Int J Methods Psychiatr Res 1995;5: 237-249.
25. Kovacs M: The Children's Depression Inventory (CDI). Psychopharmacol Bull 1985-121:995-998.
26. Reynolds CR, Richmond BO: What I think and feel: A revised measure of children's manifest anxiety. J Abnorm Child Psychol 1978-16:271-280.
27. Conners CK: The computerized Continuous Performance Test. Psychopharmacol Bull 1985;21:891-892.
28. Achenbach TM, Edelbrock C: Manual for the Child Behavior Checklist and Revised Child Behavior Profile. Burlington, VT, Queen City Printers, 1983.
29. Aldenkamp AP, Vermeulen J: Cognitive side effects of antiepileptic drugs, in Pellock JM, Dodson WE, Bourgeois BFD (eds): Pediatric Epilepsy: Diagnosis and Therapy, 2nd ed. New York, Demos Publishing, Inc, 2001, 629-635.
30. Bourgeois BF: Differential cognitive effects of antiepileptic drugs. J Child Neurol 2002;17(Suppl 2):2S28-2S33.
31. Bourgeois BFD: Determining the effects of antiepileptic drugs on cognitive function in pediatric patients with epilepsy. J Child Neurol 2004;19(Suppl 1):S15-S24.
32. Dunn DW, Austin JK: Behavioral issues in pediatric epilepsy. Neurology 1999;53(5 Suppl 23):S96-S100.
33. Kanner AM, Balabanov A: Depression and epilepsy: How closely related are they? Neurology 2002;58(8 Suppl 5):S27-S39.
34. Brent DA, Crumrine PK, Varma RR, et al: Phenobarbital treatment and major depressive disorder in children with epilepsy. Pediatrics 1987;80:909-917.
35. Glauser TA: Behavioral and psychiatric adverse events associated with antiepileptic drugs commonly used in pediatric patients. J Child Neurol 2004;19(Suppl 1):S25-S38.
36. Weckerly J: Pediatric bipolar mood disorder. J Dev Behav Pediatr 2002;23:42-56.
37. Kim EY, Miklowitz DJ: Childhood mania, attention deficit hyperactivity disorder and conduct disorder: A critical review of diagnostic dilemmas. Bipolar Disord 2002;4:215-225.
38. Ryan ND, Puig-Antich J, Ambrosini P, et al: The clinical picture of major depression in children and adolescents. Arch Gen Psychiatry 1987;44:854-861.
39. Trevathan E: Seizures and epilepsy among children with language regression and autistic spectrum disorders. J Child Neurol 2004;19(Suppl 1):S49-S57.
40. Shields WD: Management of epilepsy in mentally retarded children using the newer antiepileptic drugs, vagus nerve stimulation, and surgery. J Child Neurol 2004; 19(Suppl 1):S58-S64.
41. Rajna P, Veres J: Correlations between night sleep duration and seizure frequency in temporal lobe epilepsy. Epilepsia 1993; 34:574-579.
42. Cortesi F, Giannotti F, Ottaviano S: Sleep problems and daytime behavior in childhood idiopathic epilepsy. Epilepsia 1999;40: 1557-1565.
43. Vaughn BV, D'Cruz OF, Beach R, Messenheimer JA: Improvement of epileptic seizure control with treatment of obstructive sleep apnoca. Seizure 1996;5:73-78.
44. Hudson JI, Lipinski JF, Keck PE Jr, et al: Polysomnographic characteristics of young manic patients. Comparison with unipolar depressed patients and normal control subjects. Arch Gen Psychiatry 1992;49:378-383.
45. Ohayon MM, Caulet M, Lemoine P: Comorbidity of mental and insomnia disorders in the general population. Compr Psychiatry 1998;39:185-197.
46. Owens JA, Maxim R, Nobile C, et al: Parental and self-report of sleep in children with attention-deficit/hyperactivity disorder. Arch Pediatr Adolesc Med 2000-1154:549-555.
47. Amir N, Gross-Tsur V. Paradoxical normalization in childhood epilepsy. Epilepsia 1994;35:1060-1064.
48. Ebert U: Basic mechanisms of psychotropic drugs. Epilepsia 2002-143(Suppl 2):2-7.
49. Pisani F, Oteri G, Costa C, et al: Effects of psychotropic drugs on seizure threshold. Drug Saf 2002;25:91-110.
50. Efron D, Jarman F, Barker M: Side effects of methylphenidate and dexamphetamine in children with attention deficit hyperactivity disorder: A double-blind, crossover trial. Pediatrics 1997;100: 662-666.
51. Fischer JH: Drug interactions with antiepileptic drugs. 2001. Available at: http://www.cnsnewsse.com/indexpub.cfm?pubid=13. Accessed September 10, 2003.
52. Shorvon S: Antiepileptic drugs, in Shorvon S: Handbook of Epilepsy Treatment. Oxford, UK, Blackwell Science Ltd, 2000, 85-172.
53. Kanner AM, Dunn DW: Diagnosis and management of depression and psychosis in children and adolescents with epilepsy. J Child Neurol 2004;19(Suppl 1):S65-S72.
54. Wheless JW, Ng Y: Levetiracetam in refractory pediatric epilepsy. J Child Neurol 2002;17:413-415.
55. Sankar R, Holmes GL: Mechanisms of action for the commonly used antiepileptic drugs: relevance to antiepileptic drug-associated neurobehavioral adverse events. J Child Neurol 2004;19(Suppl 1):S6-S14.
56. Lamictal, package insert. Research Triangle Park, NC, Glaxo-SmithKline, 2003.
57. Depakote, package insert. North Chicago, IL, Abbott Laboratories, 2002.
58. Wheless JW, Bourgeois BFD: Choosing antiepileptic drugs for developmentally nonnal children with specific epilepsy syndromes and behavioral disorders. J Child Neurol 2004;19(Suppl 1):S39-S48.